Business / Finance

RSS

SynGen announces securement of additional financing from San Francisco-based life sciences venture capital firm

SynGen, Inc., a company that focuses on the development and commercialization of instrument systems that harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood, and cell culture, announced today that it has secured additional financing from Bay City Capital, LLC, a San Francisco-based life sciences venture capital firm.

6 Oct 2014

Bitplane and microDimensions announce partnership to bring Voloom to the wider life sciences market

Bitplane, an Oxford Instruments company and microDimensions today announce a partnership to bring Voloom, from microDimensions, to the wider life sciences market via the Bitplane sales channels.

From microDimensions - Bramlage Scientific GmbH 3 Oct 2014

BioCap conference showcased life sciences companies in the North

The unique BioCap conference organised by Bionow, a not for profit membership organisation for the biomedical / life-sciences industry, was a great success, combining the forces of science and financial investment enabling businesses from all over the North to secure essential funding.

3 Oct 2014

Sigma-Aldrich enters into agreement to acquire Cell Marque to better serve IHC customers

Sigma-Aldrich Corporation announced today that it has entered into an agreement to acquire Rocklin, California, based Cell Marque Corporation in a move to strengthen its antibody portfolio and to better serve immunohistochemistry (IHC) customers.

3 Oct 2014

Cepheid to acquire LABSCO's customer relationships for $21M

Cepheid today announced that, effective today, it has entered into a purchase agreement to acquire the customer relationships from its former distribution partner, the Laboratory Supply Company (LABSCO).

3 Oct 2014

Ganymed, BioNTech AG open new headquarters and research facility in Germany

BioNTech AG and Ganymed Pharmaceuticals AG, two premier German biotechology companies, announced today the joint- opening of a new approx. 10,000 square-meters (108,000 square-feet) headquarters and research facility.

1 Oct 2014

GSK awards milestone payment to Isis Pharmaceuticals to develop ISIS-GSK4Rx for ocular disease

Isis Pharmaceuticals, Inc. announced today that it has earned a $1.5 million milestone payment from GSK related to the advancement of the program to develop ISIS-GSK4Rx to treat an undisclosed ocular disease.

1 Oct 2014

Cardinal Health releases 2014 digital report and annual report for shareholders

The Cardinal Health 2014 digital report to shareholders is now available. Interested parties can learn about the company's fiscal year performance and how Cardinal Health is supporting the health care continuum by accessing the report at http://cardinalhealth.com/annualreport.

1 Oct 2014

M.E.D. Surgical to market GBUK’s products across Republic of Ireland, Northern Ireland

GBUK Ltd has announced that it has agreed an exclusive distribution deal which will see M.E.D. Surgical represent the company across the Republic of Ireland and Northern Ireland.

1 Oct 2014

Hercules Technology Growth Capital issues advance payment to Alimera Sciences

Alimera Sciences, Inc. (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that it has received a $25 million advance from Hercules Technology Growth Capital, Inc. (NYSE: HTGC) (Hercules).

1 Oct 2014

IBM extends multiyear services agreement with AmerisourceBergen

IBM (NYSE: IBM) today announced that it has extended, by three years, its multiyear services agreement with AmerisourceBergen, one of the largest global pharmaceutical sourcing and distribution services companies in the world.

1 Oct 2014

Dandrit Biotech A/S Signs Agreement To Commence Clinical Trials Of Melcancervac®

DanDrit Biotech A/S ("DanDrit Denmark"), the subsidiary of DanDrit Biotech USA, Inc. ("DanDrit"), a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, signed a contract of collaboration with the University Hospital IRCCS "San Martino" - IST – National Institute for Cancer Research known as the San Martino Hospital of Genoa.

30 Sep 2014

Allakos secures additional $10M investment to expand its development portfolio

Allakos Inc. announced today that it has secured an additional $10 million investment from current investors to fund development of an additional therapeutic antibody.

30 Sep 2014

Acutus Medical concludes additional $26.2M financing round to broaden its product portfolio

Acutus Medical, Inc. (ACM), a medical device company developing a minimally invasive real-time 3D Cardiac Chamber Imaging and Dipole Density Mapping system to identify the sources that cause and / or sustain complex cardiac arrhythmias, including atrial fibrillation, announced it has completed an additional $26.2M financing to continue developing its imaging/mapping system as well as bring to market a complete product portfolio.

30 Sep 2014

Johnson & Johnson inks definitive deal to acquire Alios BioPharma

Johnson & Johnson today announced a definitive agreement to acquire Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.75 billion in cash.

30 Sep 2014

ChromaDex closes $5.0 million growth capital debt financing

ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that it closed on a $5.0 million growth capital debt financing from Hercules Technology Growth Capital.

30 Sep 2014

Primco Management announces acquisition of 51% interest in Pops Edibles

Primco Management Inc., a medical marijuana, real estate management and multi-media company today announced that the Company has acquired a 51% interest in Pops Edibles, a San Francisco bay area based medical marijuana boutique that specializes in the formulation and manufacture of both Tetrahydrocannabinol ("THC") and Cannabidiol ("CBD") based 100% organic lollipops designed for both the medical and recreational communities.

30 Sep 2014

Baxter to establish new innovation and R&D center in Cambridge, MA

BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a new lease for approximately 200,000 square feet for 12 years with Baxter Healthcare Corporation, a subsidiary of Baxter International Inc., at 650 East Kendall Street in Cambridge, Massachusetts, which is owned by BioMed Realty through a joint venture with Prudential Real Estate Investors.

From Baxter International Inc. 30 Sep 2014

Pharmacy Value Management Solutions and Jeff Liva sign marketing deal

Advanzeon Solutions, Inc., ("Advanzeon" or the "Company"), which provides behavioral health, wellness, pharmacy management services and sleep apnea programs, to employers, Taft-Hartley health and welfare funds, managed care companies throughout the U.S. today announced that its wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS"), has entered into a marketing agreement (the "Agreement") with Jeff Liva & Co. ("Dr. Liva"), whereby Dr. Liva, through his Preventive PLUS division will, among other things, introduce the Company's programs to his existing and potential clients and recommend the programs for inclusion in his clients' healthcare benefit packages.

30 Sep 2014

Avanir Pharmaceuticals closes public offering of 20,930,000 shares of common stock

Avanir Pharmaceuticals, Inc. today announced the closing of its previously announced public offering of 20,930,000 shares of its common stock, including 2,730,000 shares sold pursuant to the underwriters' full exercise of their option to purchase additional shares, at a price to the public of $11.00 per share, before underwriting discounts.

29 Sep 2014

Business / Finance

SynGen announces securement of additional financing from San Francisco-based life sciences venture capital firm

Bitplane and microDimensions announce partnership to bring Voloom to the wider life sciences market

BioCap conference showcased life sciences companies in the North

Sigma-Aldrich enters into agreement to acquire Cell Marque to better serve IHC customers

Cepheid to acquire LABSCO's customer relationships for $21M

Ganymed, BioNTech AG open new headquarters and research facility in Germany

GSK awards milestone payment to Isis Pharmaceuticals to develop ISIS-GSK4Rx for ocular disease

Cardinal Health releases 2014 digital report and annual report for shareholders

M.E.D. Surgical to market GBUK’s products across Republic of Ireland, Northern Ireland

Hercules Technology Growth Capital issues advance payment to Alimera Sciences

IBM extends multiyear services agreement with AmerisourceBergen

Dandrit Biotech A/S Signs Agreement To Commence Clinical Trials Of Melcancervac®

Allakos secures additional $10M investment to expand its development portfolio

Acutus Medical concludes additional $26.2M financing round to broaden its product portfolio

Johnson & Johnson inks definitive deal to acquire Alios BioPharma

ChromaDex closes $5.0 million growth capital debt financing

Primco Management announces acquisition of 51% interest in Pops Edibles

Baxter to establish new innovation and R&D center in Cambridge, MA

Pharmacy Value Management Solutions and Jeff Liva sign marketing deal

Avanir Pharmaceuticals closes public offering of 20,930,000 shares of common stock

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News